Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-023150
Filing Date
2017-03-28
Accepted
2017-03-28 16:27:41
Documents
1
Period of Report
2017-03-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4589
  Complete submission text file 0001209191-17-023150.txt   6106
Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address
Viswanathan Ravi (Reporting) CIK: 0001479386 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 17719292

Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)